ProtoKinetix

ProtoKinetix Intangible Assets

The Intangible Assets of ProtoKinetix (PKTX) as of Nov 19, 2026 is 469,800.00 USD. In the previous year, Intangible Assets was 459,100.00 USD — a change of 2.33% (higher).

Intangible Assets

469,800.00USD

YoY

2.33%

Last updated:

Intangible Assets of ProtoKinetix is 2024 469,800.00 USD. Intangible Assets of ProtoKinetix was 2023 459,100.00 USD. It decreases by 2.33% higher compared to the previous year.

The ProtoKinetix Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
153,000.00 USD
Jan 1, 2018
187,800.00 USD
Jan 1, 2019
207,500.00 USD
Jan 1, 2020
274,700.00 USD
Jan 1, 2021
362,700.00 USD
Jan 1, 2022
436,300.00 USD
Jan 1, 2023
459,100.00 USD
Jan 1, 2024
469,800.00 USD
The ProtoKinetix Intangible Assets history
YEARIntangible AssetsYoY
469,800.00USD+2.33%
459,100.00USD+5.23%
436,300.00USD+20.29%
362,700.00USD+32.03%
274,700.00USD+32.39%
207,500.00USD+10.49%
187,800.00USD+22.75%
153,000.00USD+51.94%
100,700.00USD+43.24%
70,300.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProtoKinetix Stock analysis

What does ProtoKinetix do? ProtoKinetix Inc. is a Canadian biotechnology company focused on the development of glycoproteins for therapeutic applications. The company was founded in 2005 and is headquartered in Marietta, USA. ProtoKinetix specializes in the research and development of AAGP® (Anti-Aging Glycopeptide) as biopharmaceuticals. These proprietary glycoproteins have the ability to protect cells and can be used in various therapeutic applications for improving damage in physical injury, spinal cord injury, diabetes, transplantation, and retinal diseases. In addition to the medical field, ProtoKinetix is also developing its patented technology for use in bio-agriculture and animal healthcare. It has a subsidiary that holds the rights to use and distribute AAGP® and its patents. ProtoKinetix's business model involves licensing its glycoprotein technology for various applications, including biopharmaceuticals, bioprocessing industries, and cell protection management for regenerative medicine and stem cell preparations. The company has established partnerships with other biotech companies to integrate its AAGP® technology into their product pipelines. ProtoKinetix's flagship product is the AAGP® protein solution, which is used as a medication in regenerative medicine, organ transplantation, eye healing, and animal health. It is also interested in researching the application of AAGP® in crop farming to increase yields and improve soil quality. ProtoKinetix is poised to play a significant role in the development of glycoproteins as future medicines and therapeutic technologies in various industries. It not only has the potential to explore healing medical products but also aims to enhance agriculture and animal care. ProtoKinetix represents an excellent example of a biotechnology company focused on improving the healthcare and agricultural industries. ProtoKinetix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProtoKinetix stock

Intangible Assets of ProtoKinetix is 469,800.00 USD in 2024.

Intangible Assets of ProtoKinetix changed from 459,100.00 USD to 469,800.00 USD, representing a 2.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets ProtoKinetix since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's ProtoKinetix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ProtoKinetix

All Key Metrics — ProtoKinetix